Evidence map›Paper›PMID 30312113›Full record

ArticleJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics2018

Safety and Tolerability of Overdosed Artificial Tears by Abraded Rabbit Corneas.

Philippe Daull, Elisabeth Raymond, Laurence Feraille, Jean-Sébastien Garrigue

Open access · hybridAbstract read
In one paragraph

Article in Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. A novel ophthalmic latanoprost 0.005% nanoemulsion: a cytotoxicity study.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2022
    Article
  4. Article
  5. Article
  6. Topical Application of a Novel Harderian-Derived Nonpolar Lipid Prolongs Tear Film Breakup Time in Normal Beagle Dogs.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
    Article
  7. Cationic Emulsion-Based Artificial Tears as a Mimic of Functional Healthy Tear Film for Restoration of Ocular Surface Homeostasis in Dry Eye Disease.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Philippe DaullSANTEN SAS, Novagali Innovation Center, Evry Cedex, France.
Elisabeth RaymondIris Pharma, La Gaude, France.
Laurence FerailleIris Pharma, La Gaude, France.
Jean-Sébastien GarrigueSANTEN SAS, Novagali Innovation Center, Evry Cedex, France.
Institute for Radiological Image Sciences · USSanten (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Corneal InjuriesEpithelium, CornealAnimalsDiagnostic Techniques, OphthalmologicalDrug CombinationsDry Eye SyndromesEmulsionsFatty AlcoholsFemaleLubricant Eye DropsOphthalmic SolutionsPolyvinyl AlcoholPovidoneQuaternary Ammonium CompoundsRabbitsSurface-Active AgentsCationormcetalkonium chlorideDrug CombinationsEmulsionsFatty AlcoholsLubricant Eye DropsOphthalmic SolutionsPolyvinyl AlcoholPovidoneQuaternary Ammonium CompoundsSurface-Active Agentscationic emulsionscornea abrasionin vivo modelsafety evaluationwound healing

Identifiers

PMID30312113
PMCPMC6302909
OpenAlexW2896098448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.